Thyroid function and prevalent and incident metabolic syndrome in older adults: the Health, Ageing and Body Composition Study.

OBJECTIVE: Both subclinical hypothyroidism and the metabolic syndrome have been associated with increased risk of coronary heart disease events. It is unknown whether the prevalence and incidence of metabolic syndrome is higher as TSH levels increase, or in individuals with subclinical hypothyroidism. We sought to determine the association between thyroid function and the prevalence and incidence of the metabolic syndrome in a cohort of older adults. DESIGN: Data were analysed from the Health, Ageing and Body Composition Study, a prospective cohort of 3075 community-dwelling US adults. PARTICIPANTS: Two thousand one hundred and nineteen participants with measured TSH and data on metabolic syndrome components were included in the analysis. MEASUREMENTS: TSH was measured by immunoassay. Metabolic syndrome was defined per revised ATP III criteria. RESULTS: At baseline, 684 participants met criteria for metabolic syndrome. At 6-year follow-up, incident metabolic syndrome developed in 239 individuals. In fully adjusted models, each unit increase in TSH was associated with a 3% increase in the odds of prevalent metabolic syndrome (OR, 1.03; 95% CI, 1.01-1.06; P = 0.02), and the association was stronger for TSH within the normal range (OR, 1.16; 95% CI, 1.03-1.30; P = 0.02). Subclinical hypothyroidism with a TSH > 10 mIU/l was significantly associated with increased odds of prevalent metabolic syndrome (OR, 2.3; 95% CI, 1.0-5.0; P = 0.04); the odds of incident MetS was similar (OR 2.2), but the confidence interval was wide (0.6-7.5). CONCLUSIONS: Higher TSH levels and subclinical hypothyroidism with a TSH > 10 mIU/l are associated with increased odds of prevalent but not incident metabolic syndrome.

BCR and TLR signalling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas.

The genetics and pathogenesis of splenic marginal zone lymphoma are poorly understood. The lymphoma lacks chromosome translocation, and ~30% of cases are featured by 7q deletion, but the gene targeted by the deletion is unknown. A recent study showed inactivation of A20, a 'global' NF-kB negative regulator, in 1 of 12 splenic marginal zone lymphoma. To investigate further whether deregulation of the NF-kB pathway plays a role in the pathogenesis of splenic marginal zone lymphoma, we screened several NF-kB regulators for genetic changes by PCR and sequencing. Somatic mutations were found in A20 (6/46=13%), MYD88 (6/46=13%), CARD11 (3/34=8.8%), but not in CD79A, CD79B and ABIN1. Interestingly, these genetic changes are largely mutually exclusive from each other and MYD88 mutation was also mutually exclusive from 7q deletion. These results strongly suggest that deregulation of the TLR (toll like receptor) and BCR (B-cell receptor) signalling pathway may play an important role in the pathogenesis of splenic marginal zone lymphoma.

Impact of an intervention to control risk associated with patient transfer.

QUESTION UNDER STUDY: Hospitals transferring patients retain responsibility until admission to the new health care facility. We define safe transfer conditions, based on appropriate risk assessment, and evaluate the impact of this strategy as implemented at our institution. METHODS: An algorithm defining transfer categories according to destination, equipment monitoring, and medication was developed and tested prospectively over 6 months. Conformity with algorithm criteria was assessed for every transfer and transfer category. After introduction of a transfer coordination centre with transfer nurses, the algorithm was implemented and the same survey was carried out over 1 year. RESULTS: Over the whole study period, the number of transfers increased by 40%, chiefly by ambulance from the emergency department to other hospitals and private clinics. Transfers to rehabilitation centres and nursing homes were reassigned to conventional vehicles. The percentage of patients requiring equipment during transfer, such as an intravenous line, decreased from 34% to 15%, while oxygen or i.v. drug requirement remained stable. The percentage of transfers considered below theoretical safety decreased from 6% to 4%, while 20% of transfers were considered safer than necessary. A substantial number of planned transfers could be "downgraded" by mutual agreement to a lower degree of supervision, and the system was stable on a short-term basis. CONCLUSION: A coordinated transfer system based on an algorithm determining transfer categories, developed on the basis of simple but valid medical and nursing criteria, reduced unnecessary ambulance transfers and treatment during transfer, and increased adequate supervision.

Infections nosocomiales : interventions et qualité des soins [Maladies infectieuses = Nosocomial infections : quality improvement interventions]

Le développement de méthodes de mesure de la qualité des soins et les actions visant à son amélioration font partie intégrante de la pratique quotidienne. Les infections nosocomiales représentent un Indicateur Incontournable et leur prévention apparaît comme un champ d'action privilégié du concept de l'amélioration continue de la qualité des soins. Dans ce domaine, de nombreuses mesures ont fait l'objet d'études répondant à des critères méthodologiques de qualité élevée, dont les résultats sont hautement significatifs au plan statistique. Les interventions complexes concernant par exemple l'ensemble des patients d'un service ou d'une institution ne permettent que difficilement de satisfaire à ces exigences méthodologiques. Sous certaines conditions, elle peuvent cependant avoir un impact réel et parfois durable sur la qualité des soins. A titre d'exemple, nous discutons deux interventions complexes dans le domaine de la prévention des infections nosocomiales, résultant de démarches visant à une amélioration globale et durable de la qualité des soins. L'utilisation d'outils épidémiologiques adaptés permet également d'estimer le bénéfice des Interventions en milieu hospitalier conformément à ce que la communauté scientifique reconnaît comme étant une recherche clinique de qualité.

Effects of MRI scan acceleration on brain volume measurement consistency.

PURPOSE: To evaluate the effects of recent advances in magnetic resonance imaging (MRI) radiofrequency (RF) coil and parallel imaging technology on brain volume measurement consistency. MATERIALS AND METHODS: In all, 103 whole-brain MRI volumes were acquired at a clinical 3T MRI, equipped with a 12- and 32-channel head coil, using the T1-weighted protocol as employed in the Alzheimer's Disease Neuroimaging Initiative study with parallel imaging accelerations ranging from 1 to 5. An experienced reader performed qualitative ratings of the images. For quantitative analysis, differences in composite width (CW, a measure of image similarity) and boundary shift integral (BSI, a measure of whole-brain atrophy) were calculated. RESULTS: Intra- and intersession comparisons of CW and BSI measures from scans with equal acceleration demonstrated excellent scan-rescan accuracy, even at the highest acceleration applied. Pairs-of-scans acquired with different accelerations exhibited poor scan-rescan consistency only when differences in the acceleration factor were maximized. A change in the coil hardware between compared scans was found to bias the BSI measure. CONCLUSION: The most important findings are that the accelerated acquisitions appear to be compatible with the assessment of high-quality quantitative information and that for highest scan-rescan accuracy in serial scans the acquisition protocol should be kept as consistent as possible over time. J. Magn. Reson. Imaging 2012;36:1234-1240. ©2012 Wiley Periodicals, Inc.

Swiss clinical practice guidelines on field cancerization of the skin.

Actinic keratosis (AK) affects millions of people worldwide, and its prevalence continues to increase. AK lesions are caused by chronic ultraviolet radiation exposure, and the presence of two or more AK lesions along with photodamage should raise the consideration of a diagnosis of field cancerization. Effective treatment of individual lesions as well as field cancerization is essential for good long-term outcomes. The Swiss Registry of Actinic Keratosis Treatment (REAKT) Working Group has developed clinical practice guidelines for the treatment of field cancerization in patients who present with AK. These guidelines are intended to serve as a resource for physicians as to the most appropriate treatment and management of AK and field cancerization based on current evidence and the combined practical experience of the authors. Treatment of AK and field cancerization should be driven by consideration of relevant patient, disease, and treatment factors, and appropriate treatment decisions will differ from patient to patient. Prevention measures and screening recommendations are discussed, and special considerations related to management of immunocompromised patients are provided.

Role of fibroblast growth factor (FGF) signaling in the neuroendocrine control of human reproduction.

Fibroblast growth factor (FGF) signaling is critical for a broad range of developmental processes. In 2003, Fibroblast growth factor receptor 1 (FGFR1) was discovered as a novel locus causing both forms of isolate GnRH Deficiency, Kallmann syndrome [KS with anosmia] and normosmic idiopathic hypogonadotropic hypogonadism [nIHH] eventually accounting for approximately 10% of gonadotropin-releasing hormone (GnRH) deficiency cases. Such cases are characterized by a broad spectrum of reproductive phenotypes from severe congenital forms of GnRH deficiency to reversal of HH. Additionally, the variable expressivity of both reproductive and non-reproductive phenotypes among patients and family members harboring the identical FGFR1 mutations has pointed to a more complex, oligogenic model for GnRH deficiency. Further, reversal of HH in patients carrying FGFR1 mutations suggests potential gene-environment interactions in human GnRH deficiency disorders.

Financial impact of introducing the Swiss-DRG reimbursement system on potentially avoidable readmissions at a university hospital.

QUESTION UNDER STUDY: Thirty-day readmissions can be classified as potentially avoidable (PARs) or not avoidable (NARs) by following a specific algorithm (SQLape®). We wanted to assess the financial impact of the Swiss-DRG system, which regroups some readmissions occurring within 18 days after discharge within the initial hospital stay, on PARs at our hospital. METHODS: First, PARs were identified from all hospitalisations recorded in 2011 at our university hospital. Second, 2012 Swiss-DRG readmission rules were applied, regrouped readmissions (RR) were identified, and their financial impact computed. Third, RRs were classified as potentially avoidable (PARRs), not avoidable (NARRs), and others causes (OCRRs). Characteristics of PARR patients and stays were retrieved, and the financial impact of PARRS was computed. RESULTS: A total of 36,777 hospitalisations were recorded in 2011, of which 3,140 were considered as readmissions (8.5%): 1,470 PARs (46.8%) and 1,733 NARs (53.2%). The 2012 Swiss-DRG rules would have resulted in 910 RRs (2.5% of hospitalisations, 29% of readmissions): 395 PARRs (43% of RR), 181 NARRs (20%), and 334 OCRRs (37%). Loss in reimbursement would have amounted to CHF 3.157 million (0.6% of total reimbursement). As many as 95% of the 395 PARR patients lived at home. In total, 28% of PARRs occurred within 3 days after discharge, and 58% lasted less than 5 days; 79% of the patients were discharged home again. Loss in reimbursement would amount to CHF 1.771 million. CONCLUSION: PARs represent a sizeable number of 30-day readmissions, as do PARRs of 18-day RRs in the 2012 Swiss DRG system. They should be the focus of attention, as the PARRs represent an avoidable loss in reimbursement.

The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland.

OBJECTIVES: To describe disease characteristics and treatment modalities in a multidisciplinary cohort of systemic lupus erythematosus (SLE) patients in Switzerland. METHODS: Cross-sectional analysis of 255 patients included in the Swiss SLE Cohort and coming from centres specialised in Clinical Immunology, Internal Medicine, Nephrology and Rheumatology. Clinical data were collected with a standardised form. Disease activity was assessed using the Safety of Estrogens in Lupus Erythematosus National Assessment-SLE Disease Activity Index (SELENA-SLEDAI), an integer physician's global assessment score (PGA) ranging from 0 (inactive) to 3 (very active disease) and the erythrocyte sedimentation rate (ESR). The relationship between SLE treatment and activity was assessed by propensity score methods using a mixed-effect logistic regression with a random effect on the contributing centre. RESULTS: Of the 255 patients, 82% were women and 82% were of European ancestry. The mean age at enrolment was 44.8 years and the median SLE duration was 5.2 years. Patients from Rheumatology had a significantly later disease onset. Renal disease was reported in 44% of patients. PGA showed active disease in 49% of patients, median SLEDAI was 4 and median ESR was 14 millimetre/first hour. Prescription rates of anti-malarial drugs ranged from 3% by nephrologists to 76% by rheumatologists. Patients regularly using anti-malarial drugs had significantly lower SELENA-SLEDAI scores and ESR values. CONCLUSION: In our cohort, patients in Rheumatology had a significantly later SLE onset than those in Nephrology. Anti-malarial drugs were mostly prescribed by rheumatologists and internists and less frequently by nephrologists, and appeared to be associated with less active SLE.

Genome-wide association analysis identifies 20 loci that influence adult height.

Adult height is a model polygenic trait, but there has been limited success in identifying the genes underlying its normal variation. To identify genetic variants influencing adult human height, we used genome-wide association data from 13,665 individuals and genotyped 39 variants in an additional 16,482 samples. We identified 20 variants associated with adult height (P < 5 x 10(-7), with 10 reaching P < 1 x 10(-10)). Combined, the 20 SNPs explain approximately 3% of height variation, with a approximately 5 cm difference between the 6.2% of people with 17 or fewer 'tall' alleles compared to the 5.5% with 27 or more 'tall' alleles. The loci we identified implicate genes in Hedgehog signaling (IHH, HHIP, PTCH1), extracellular matrix (EFEMP1, ADAMTSL3, ACAN) and cancer (CDK6, HMGA2, DLEU7) pathways, and provide new insights into human growth and developmental processes. Finally, our results provide insights into the genetic architecture of a classic quantitative trait.

La recherche au sein des hautes écoles spécialisées 2012: descriptions, analyses, conclusions

Résumé Contexte et objectifs Les activités de recherche appliquée et développement (Ra&D) font partie du mandat de prestations des hautes écoles spécialisées (HES) prescrit par la loi. Néanmoins la tradition, le type et l'importance de la recherche varient fortement en fonction des domaines d'études. Il en va de même pour les liens avec les autres domaines de prestations que sont l'enseignement, la formation continue et les prestations de services. Les activités de Ra&D dans chaque HES s'inscrivent dans la tension entre l'orientation pratique (qui signifie le plus souvent une orientation vers le marché économique) et l'orientation vers la science (signe de leur rattachement au système scientifique). Il en découle des conflits d'intérêts entre les critères de qualité du « succès sur le marché » et de la « réputation scientifique ». En 2005, sur mandat de la Commission pour la technologie et l'innovation (CTI), B. Lepori et L. Attar (2006) ont mené une étude visant à examiner plus particulièrement les stratégies de recherche et l'organisation de la recherche au sein des hautes écoles spécialisées. Aujourd'hui, six ans plus tard, la phase de mise sur pied est en grande partie terminée. En lançant une nouvelle étude, l'Office fédéral de la formation professionnelle et de la technologie (OFFT) et la Commission fédérale des hautes écoles spécialisées (CFHES) souhaitaient faire le point sur les activités de recherche des HES, c'està- dire examiner les résultats des stratégies et de l'organisation de cette phase. Cette étude s'articule principalement autour de l'état actuel de la recherche, de ses problèmes et de ses perspectives. Structure de l'étude La recherche dans les HES se caractérise par différents facteurs d'influence (cultures disciplinaires, traditions, ancrage dans les régions linguistiques, structures organisationnelles, gouvernance, stratégies de positionnement, personnel, etc.). Dans la présente étude, ces facteurs sont systématiquement examinés selon deux dimensions: le « domaine d'études » et la « haute école spécialisée». L'analyse repose notamment sur l'exploitation de documents et de données. Mais cette étude se fonde principalement sur les entretiens menés avec les représentants des HES à différents niveaux de responsabilités. Les hautes écoles spécialisées (HES) Les entretiens avec les directions des HES ainsi que l'exploitation des données et des documents mettent en évidence la grande diversité des sept HES suisses de droit public dans leur structure, leurs combinaisons de domaines d'études et leurs orientations. Les modes de financement de la recherche varient fortement entre les HES. Concrètement, les sources de financement ne sont pas les mêmes d'une HES à l'autre (contributions des organes responsables, fonds de tiers, etc.). Les degrés et formes du pilotage concernant les contenus de la recherche diffèrent également dans une large mesure (définition de pôles de recherche, soutien cumulatif à l'acquisition de fonds de tiers), de même que les stratégies en matière de recrutement et d'encouragement du personnel. La politique de chaque HES implique des tensions et des problèmes spécifiques. Les domaines d'études Sur les dix domaines d'études, quatre ont été choisis à titre d'exemples pour des études approfondies : Technique et technologies de l'information (TI), Economie et services, Travail social, Musique, arts de la scène et autres arts. Chaque domaine d'études a été examiné à chaque fois dans deux HES. Cette méthode permet de relever les différences et les similitudes. Les résultats confirment qu'il existe des différences importantes à bien des égards entre les domaines d'études évalués. Ces différences concernent la position dans le système des hautes écoles, le volume des activités de recherche, l'importance de la recherche au sein des HES, la tradition, l'identité et l'orientation. Elles se retrouvent par ailleurs dans les buts et la place de la Ra&D dans les domaines d'études concernés. Il ressort toutefois qu'il n'y a pas lieu de parler d'une dichotomie entre les « anciens » et les « nouveaux » domaines d'études : Technique, économie et design (TED) d'une part et Santé, social et arts (SSA) d'autre part. Il semble plus pertinent de désigner le domaine d'études 4/144 Technique et TI comme le domaine dominant auquel se référent le pilotage et le financement des HES, que ce soit implicitement ou explicitement. Cadre homogène et espaces hétérogènes Le pilotage et le financement de la Ra&D au sein des hautes écoles spécialisées s'inscrivent dans un modèle-cadre fixé à l'échelle fédérale et principalement axé sur le domaine d'études Technique. Ce modèle-cadre se caractérise par un apport élevé de fonds de tiers (notamment les subventions de la CTI et les fonds privés) et des incitations en faveur de ce mode de financement, par une orientation vers le marché et par un haut degré d'autonomie des établissements partenaires/départements et instituts. Par comparaison avec les hautes écoles universitaires, les HES affichent notamment un faible niveau de financement de base dans le secteur Ra&D. Cet état de fait est certes compatible avec la forme actuelle du financement par la CTI, mais pas avec les règles de financement du Fonds national suisse (FNS). Un financement principalement basé sur les fonds de tiers signifie par ailleurs que l'orientation du contenu de la recherche et la définition de critères de qualité sont confiées à des instances externes, notamment aux mandants et aux institutions d'encouragement de la recherche. Il apparaît en dernier lieu qu'un tel modèle-cadre ne favorise pas les politiques visant à la constitution de pôles de recherche, l'obtention d'une taille critique, et la mise en place d'une coordination. Ces résultats concernent tous les domaines d'études sans avoir pour autant les mêmes conséquences : les domaines d'études se prêtant dans une faible mesure à l'acquisition de fonds de tiers sur des marchés économiques (dans cette étude, il s'agit essentiellement de la Musique, arts de la scène et autres arts, mais également du Travail social dans certains cas) ont plus de difficultés à répondre aux attentes énoncées en termes de succès et de profit. Les HES modifient plus ou moins le modèle-cadre en élaborant elles-mêmes des modèles d'organisation qui prennent en compte leur combinaison de domaines d'études et soutiennent leurs propres orientations et positionnements stratégiques. La combinaison de domaines d'études hétérogènes et de politiques différentes au sein des HES se traduit par une complexité du système des HES, beaucoup plus importante que ce que généralement supposée. De plus, au regard des connaissances lacunaires sur les structures « réelles » de gouvernance des HES, il n'est quasiment pas possible de comparer directement les hautes écoles spécialisées entre elles. Conclusions et recommandations Le principal constat qui ressort d'un ensemble de conclusions et de recommandations des auteurs est que le secteur Ra&D dans les HES doit être plus explicitement évalué en fonction des spécificités des domaines d'études, à savoir du rôle de la recherche pour l'économie et la société, des différences entre les marchés (économiques) correspondants et de l'importance de la Ra&D pour les objectifs visés. L'étude montre clairement qu'il n'y a pas à proprement parler une seule et unique recherche au sein des hautes écoles spécialisées et que la notion de « recherche appliquée » ne suffit ni comme description ni, par conséquence, comme critère d'identité commun. Partant de ce constat, nous recommandons de revoir le mode de financement de la recherche dans les HES et d'approfondir le débat sur les structures de gouvernance sur l'orientation de la Ra&D (et notamment sur les critères de qualité appliqués), de même que sur l'autonomie et la coordination. Les recommandations constituent des points de discussion et n'engagent aucunement l'OFFT ou la CFHES.

Comprehensive clinical and molecular analysis of 12 families with type 1 recessive cutis laxa.

Autosomal recessive cutis laxa type I (ARCL type I) is characterized by generalized cutis laxa with pulmonary emphysema and/or vascular complications. Rarely, mutations can be identified in FBLN4 or FBLN5. Recently, LTBP4 mutations have been implicated in a similar phenotype. Studying FBLN4, FBLN5, and LTBP4 in 12 families with ARCL type I, we found bi-allelic FBLN5 mutations in two probands, whereas nine probands harbored biallelic mutations in LTBP4. FBLN5 and LTBP4 mutations cause a very similar phenotype associated with severe pulmonary emphysema, in the absence of vascular tortuosity or aneurysms. Gastrointestinal and genitourinary tract involvement seems to be more severe in patients with LTBP4 mutations. Functional studies showed that most premature termination mutations in LTBP4 result in severely reduced mRNA and protein levels. This correlated with increased transforming growth factor-beta (TGFβ) activity. However, one mutation, c.4127dupC, escaped nonsense-mediated decay. The corresponding mutant protein (p.Arg1377Alafs(*) 27) showed reduced colocalization with fibronectin, leading to an abnormal morphology of microfibrils in fibroblast cultures, while retaining normal TGFβ activity. We conclude that LTBP4 mutations cause disease through both loss of function and gain of function mechanisms.

An algebraic operator approach to the analysis of Gerber-Shiu functions

We introduce an algebraic operator framework to study discounted penalty functions in renewal risk models. For inter-arrival and claim size distributions with rational Laplace transform, the usual integral equation is transformed into a boundary value problem, which is solved by symbolic techniques. The factorization of the differential operator can be lifted to the level of boundary value problems, amounting to iteratively solving first-order problems. This leads to an explicit expression for the Gerber-Shiu function in terms of the penalty function.

Variants in MTNR1B influence fasting glucose levels.

To identify previously unknown genetic loci associated with fasting glucose concentrations, we examined the leading association signals in ten genome-wide association scans involving a total of 36,610 individuals of European descent. Variants in the gene encoding melatonin receptor 1B (MTNR1B) were consistently associated with fasting glucose across all ten studies. The strongest signal was observed at rs10830963, where each G allele (frequency 0.30 in HapMap CEU) was associated with an increase of 0.07 (95% CI = 0.06-0.08) mmol/l in fasting glucose levels (P = 3.2 x 10(-50)) and reduced beta-cell function as measured by homeostasis model assessment (HOMA-B, P = 1.1 x 10(-15)). The same allele was associated with an increased risk of type 2 diabetes (odds ratio = 1.09 (1.05-1.12), per G allele P = 3.3 x 10(-7)) in a meta-analysis of 13 case-control studies totaling 18,236 cases and 64,453 controls. Our analyses also confirm previous associations of fasting glucose with variants at the G6PC2 (rs560887, P = 1.1 x 10(-57)) and GCK (rs4607517, P = 1.0 x 10(-25)) loci.